| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Century Therapeutics, Inc. (IPSC) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. IPSC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.32M | $7.64M | - | |
| Other | 1.18M | $2.70M | - | |
| Other | 525.5K | $1.21M | - | |
| VP | 514.3K | $1.18M | - | |
| Dir | 88.0K | $202.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2021 | Casdin Eli50 | Director | Buy | 750,000 | $20.00 | $15,000,000.00 | +30.5% | -16.0% | -63.8% |